Raffa Wealth Management’s Editas Medicine EDIT Stock Holding History

Raffa Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62	Hold	19	–	–	﹤0.01%	1483
2026 Q1	$47	Hold	19	–	–	﹤0.01%	1399
2025 Q4	$39	Hold	19	–	–	﹤0.01%	1159
2025 Q3	$66	Hold	19	–	–	﹤0.01%	1164
2025 Q2	$42	Hold	19	–	–	﹤0.01%	1099
2025 Q1	$22	Hold	19	–	–	﹤0.01%	1075
2024 Q4	$24	Hold	19	–	–	﹤0.01%	1110
2024 Q3	$65	Hold	19	–	–	﹤0.01%	1075
2024 Q2	$89	Hold	19	–	–	﹤0.01%	1139
2024 Q1	$141	Hold	19	–	–	﹤0.01%	1106
2023 Q4	$192	Hold	19	–	–	﹤0.01%	1031
2023 Q3	$148	Hold	19	–	–	﹤0.01%	1036
2023 Q2	$156	Hold	19	–	–	﹤0.01%	1047
2023 Q1	$138	Hold	19	–	–	﹤0.01%	1052
2022 Q4	$169	Hold	19	–	–	﹤0.01%	1034
2022 Q3	$233	Hold	19	–	–	﹤0.01%	1119
2022 Q2	$225	Hold	19	–	–	﹤0.01%	1099
2022 Q1	$361	Hold	19	–	–	﹤0.01%	1086
2021 Q4	$504	Hold	19	–	–	﹤0.01%	1048
2021 Q3	$781	Hold	19	–	–	﹤0.01%	931
2021 Q2	$1.08K	Hold	19	–	–	﹤0.01%	809
2021 Q1	$798	Sell	19 -29	-60%	-$1.65K	﹤0.01%	910
2020 Q4	$3.37K	Buy	+48	New	+$1.97K	﹤0.01%	433

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Raffa Wealth Management's EDIT Position: Q2 2026 in Review

Raffa Wealth Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 19 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Raffa Wealth Management first reported a position in EDIT in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.37K in Q4 2020. 199 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Raffa Wealth Management held 19 shares of Editas Medicine worth $62 as of Q2 2026.
Raffa Wealth Management left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1483 holding.
Raffa Wealth Management first reported a position in Editas Medicine in Q4 2020 and has held it in 23 quarters since.
Raffa Wealth Management's Editas Medicine position peaked at $3.37K in Q4 2020.
199 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.